ClinicalTrials.gg
RecruitingNCT06296589PORTUpdated Aug 25, 2026

Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure

An interventional study of Trauma Informed Guilt Reduction Therapy and Prolonged Exposure Therapy in Stress Disorders, Post-Traumatic, sponsored by Veterans Medical Research Foundation. Recruiting at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Veterans Medical Research Foundation · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
158
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Stress Disorders, Post-Traumatic by Veterans Medical Research Foundation — 3 open to participants now, 3 under way, none of them phase 3. Stress Disorders, Post-Traumatic · Veterans Medical Research Foundation.

Planned enrollment
5th of 10
158 · median 152
Started
2024
with 1 other
No phase
10 of 11
3 open now
Registered
10th of 11
by date

Among the 11 studies in Stress Disorders, Post-Traumatic by Veterans Medical Research Foundation, this one is the 5th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2024, is one of 10 with no phase, and was the 10th registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

3 of the 11 studies in Stress Disorders, Post-Traumatic by Veterans Medical Research Foundation are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Stress Disorders, Post-Traumatic by Veterans Medical Research Foundation, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if receiving Trauma-Informed Guilt Reduction (TrIGR) Therapy is as effective as receiving Prolonged Exposure Therapy among veterans with PTSD and trauma related guilt. The main questions it aims to answer are:

Will TrIGR be comparable to PE in terms of PTSD symptom reduction? Will it TrIGR be comparable to PE in improving functioning and reducing depression symptoms? Will it be superior in improving trauma-related guilt and shame?

Read the detailed description

Trauma-related guilt is common and impairing among trauma survivors. Guilt is positively associated with severity of PTSD and depression symptoms, poorer psychosocial functioning and suicide risk. Although existing evidence-based trauma-focused PTSD treatments such as Prolonged Exposure (PE) are effective in treating PTSD and trauma-related guilt, many still experience symptoms or maintain their diagnosis after treatment. Preliminary research shows that a brief treatment targeting trauma-related and moral injury-related guilt and shame, Trauma Informed Guilt Reduction Therapy (TrIGR), can reduce guilt, PTSD, depression, and distress among Veterans and help them reengage with meaningful activities. Whether TrIGR is comparably effective to longer, more resource heavy evidence-based PTSD treatments disseminated across DoD and VA, like PE, is a critical question.

The proposed randomized clinical trial aims to determine if TrIGR is non-inferior to a first tier PTSD treatment, PE. Hypotheses are that 6 sessions of TrIGR will be non-inferior to 12 sessions of PE in reducing PTSD symptom severity among Veterans with PTSD who endorse trauma-related guilt. Secondary aims are to evaluate the hypotheses that TrIGR will be non-inferiority relative to PE in improving psychosocial functioning and depression symptoms and superior in reducing trauma-related guilt and shame. The study will also explore treatment differences in change in suicidal ideation and dropout.

Participants will be recruited from mental health clinics across three VAs. 158 Veterans who served since 9/11 and with PTSD and guilt from any type of trauma will be included. TrIGR will be administered over 6 weekly sessions (60-minutes each) and PE will be administered over 12 weekly sessions (90 minutes each). Blind assessors will evaluate participants at baseline and 8-, 16-, and 28 weeks after the first therapy session. Inclusion and exclusion criteria are minimized so that generalizability will be high.

03

Conditions studied

  • Stress Disorders, Post-Traumatic
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • U.S. Veterans age 18 or older who served in the military since the start of Operation Enduring Freedom/Operation Iraqi Freedom; OEF/OIF)
  • meets diagnostic criteria for PTSD;
  • a score of 2 or higher ("true" to "extremely true") on feeling trauma-related guilt much or all of the time or scoring 3 or higher ("very true" or "extremely true") on at least one guilt cognition factor (hindsight bias/responsibility, wrongdoing, or lack of justification) on the Trauma Related Guilt Inventory
  • not currently receiving trauma-focused treatment such as PE or CPT
  • willingness to attend psychotherapy and assessment sessions

Exclusion criteria

Exclusion Criteria:

  • current risk of suicidal/homicidal behavior that requires immediate intervention
  • current severe substance use disorder (in the past two months) based on criteria
  • current unmanaged psychosis or mania
  • life threatening or unstable medical illness
  • inability to read
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
158 participants (estimated)

Study arms

  • Experimental
    trauma Informed Guilt Reduction Therapy

    6 session behavioral intervention focused on trauma-related guilt, shame, and moral injury

    Behavioral: Trauma Informed Guilt Reduction Therapy

  • Active comparator
    Prolonged Exposure Therapy

    12 session behavioral intervention focused on PTSD symptoms

    Behavioral: Prolonged Exposure Therapy

Interventions

  • BehavioralTrauma Informed Guilt Reduction Therapy

    Behavioral therapy for trauma related guilt and shame

  • BehavioralProlonged Exposure Therapy

    Behavioral exposure therapy for PTSD

06

What researchers measure

Primary outcomes

  1. Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

    Measures PTSD symptom severity, score range 0-80, higher scores mean greater symptom severity

    Time frame: baseline and 8-, 16-, and 28 weeks after the first therapy session

Secondary outcomes

  1. Patient Health Questionnaire-9 (PHQ-9)

    Depression symptom severity, range = 0-27, higher scores mean greater depression symptom severity

    Time frame: baseline and 8-, 16-, and 28 weeks after the first therapy session

  2. Brief Psychosocial Functioning Inventory (B-IPF)

    Measures severity of impairment in psychosocial functioning, scores = 0-100, higher scores indicate greater impairment

    Time frame: baseline and 8-, 16-, and 28 weeks after the first therapy session

  3. Trauma Related Guilt Inventory Cognitions Scale (TRGI)

    Measures severity of trauma related guilt cognitions, scores = 0-4, higher scores indicate greater guilt

    Time frame: baseline and 8-, 16-, and 28 weeks after the first therapy session

  4. Trauma Related Shame Inventory (TRSI)

    Measures severity of trauma related shame, scores = 0-96, higher scores indicate greater shame

    Time frame: baseline and 8-, 16-, and 28 weeks after the first therapy session

07

Study locations

4 of 4 sites recruiting
  • Little Rock Veterans Health Care System (LRVHCS)
    Little Rock, Arkansas 72205, United States
    Recruiting
  • VA San Diego
    San Diego, California 92161, United States
    Recruiting
    • Kaitlyn Panza · Contactkaitlyn.panza@va.gov · 858-552-8585
    • Kaitlyn Panza, PhD · Principal investigator
  • Southeast Louisiana Veterans Health Care System (SLVHCS)
    New Orleans, Louisiana 70119, United States
    Recruiting
  • William S. Middleton Memorial Hospital
    Madison, Wisconsin 53705, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Will share data with Strong Star Repository.

Supporting information: Study protocol

Time frame: After study completion.

Access criteria: Request to StrongStar Repository that Strong Star must approve.

Data sharing details ↗ · www.strongstar.org

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Jul 2027, 31 months after the start.

Of 1,066 non-industry interventional studies with no phase under Stress Disorders, Post-Traumatic, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 31 months is below that.

Counting every sponsor, half of 1,094 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 28, 2024
First posted
Mar 6, 2024
StartActual
Dec 1, 2024
Primary completionEst.
Jul 2027
CompletionEst.
Aug 2027
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06296589
Lead sponsor
Veterans Medical Research Foundation
Collaborators
University of Minnesota, Center for Veterans Research and Education
Responsible party
Sponsor
First posted
Mar 6, 2024
Start date
Dec 1, 2024
Primary completion
Jul 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Sonya Norman, PhD
Contact
snorman@ucsd.edu
858-518-8266
Kaitlyn Panza, PhD
Contact
kaitlyn.panza@va.gov
858-552-8585
Shannon Kehle-Forbes, PhD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion